Atrial fibrillation and premature ventricular complexes frequently appear together, and the combination creates clinical problems that neither condition poses on its own. PVCs can trigger new episodes of AFib, AFib makes PVCs harder to diagnose on a heart tracing, and a high PVC burden in someone already in AFib raises the risk of stroke and heart-muscle weakening beyond what AFib alone would cause. The interplay between these two arrhythmias matters more than most patients realize, and managing both well often requires a layered approach.
How PVCs and AFib Feed Each Other
PVCs and AFib are not just two unrelated electrical glitches happening in the same heart. There is a measurable connection between frequent PVCs and the onset of AFib. A propensity-matched study of patients with varying PVC loads found that those with a moderate-to-high PVC burden developed new AFib at roughly twice the rate of those with a low burden, and multivariate analysis confirmed that high PVC frequency was an independent risk factor for new-onset AFib after accounting for other cardiac variables.1PubMed Central. High Burden of Premature Ventricular Complex Increases the Risk of New‐Onset Atrial Fibrillation A large wearable-ECG study from the UK Biobank echoed this: participants who showed even a single premature contraction on a brief recording were more likely to develop AFib, heart failure, and other cardiovascular events over a median follow-up of about 11.5 years compared to those with no premature beats.2European Heart Journal – Digital Health. Premature atrial and ventricular contractions detected on wearable-format electrocardiograms and prediction of cardiovascular events
The mechanism behind this relationship involves structural remodeling. When PVCs fire frequently over weeks or months, the left atrium tends to enlarge. One study comparing PVC patients who were treated versus observed found that the untreated group developed a significant increase in left atrial diameter and a drop in heart-pumping function, while the treated group did not.3PubMed Central. Atrial and Ventricular Response to Treatment of Premature Ventricular Complexes A stretched, dilated left atrium is fertile ground for AFib to take hold, which is why controlling PVCs early can interrupt a cycle that leads to persistent AFib down the road.
What the Combination Feels Like
AFib alone commonly causes a fluttery, irregular heartbeat, fatigue, and sometimes shortness of breath or lightheadedness. PVCs alone often feel like a “skipped beat” or a sudden thud in the chest. When both are present, the symptom picture can be confusing and more distressing than either one in isolation. The irregular rhythm of AFib means you already feel your heart doing unpredictable things, and PVCs layered on top can add sudden, forceful beats that feel dramatically different from the AFib baseline. Some people describe it as their heart “catching” or “lurching” during an already unsteady rhythm.
The psychological burden is real and underappreciated. A review of studies covering over 400 patients with frequent PVCs found that successful treatment, whether through medication or ablation, led to measurable decreases in depression, anxiety, cardiac-specific fear, and stress.4Oxford Academic (EP Europace). Premature ventricular contractions and quality of life: a state-of-the-art review and psychological perspective Those patients were predominantly middle-aged and more than half were women, which fits the profile of people most bothered by palpitations. When you add AFib’s own symptom burden to PVC-related anxiety, quality of life takes a hit that goes well beyond what a heart-rate number on a monitor captures.
Why the Diagnosis Gets Tricky
One of the underappreciated challenges when AFib and PVCs coexist is telling them apart on a heart tracing. In normal sinus rhythm, a PVC is easy to spot: it looks wide and bizarre next to the narrow, normal beats. But during AFib, the heart’s rhythm is already chaotic, and something called Ashman’s phenomenon can produce wide, PVC-looking beats that are not actually PVCs at all. Ashman’s phenomenon occurs when a long pause between heartbeats is followed by a short interval, which catches one of the heart’s electrical pathways still in its recovery period. The result is a beat that looks like a PVC on the monitor but is really just the heart’s normal conduction system misfiring due to timing.5PubMed. An interesting cause of wide complex tachycardia: Ashman’s phenomenon in atrial fibrillation
Getting this distinction right matters because the treatment is completely different. True PVCs during AFib may warrant antiarrhythmic drugs or ablation, while Ashman beats are benign and need no specific therapy. Researchers have used mathematical methods analyzing the timing patterns of consecutive heartbeats to separate the two: aberrant conduction from Ashman’s phenomenon produces a characteristic pattern on timing plots, while true PVCs scatter differently and show no relationship to the underlying AFib rhythm envelope.6PubMed. Differentiation between aberrant ventricular conduction and ventricular ectopy in atrial fibrillation using RR interval scattergram In everyday clinical practice, this means your doctor may need longer monitoring and careful review rather than a snap judgment from a single ECG strip.
When PVC Burden Becomes Dangerous
Not all PVCs are created equal, and the concept of “PVC burden” is central to understanding risk. PVC burden is the percentage of your total heartbeats in a day that are PVCs. A handful of extra beats is common and harmless in most people. But when the burden climbs above roughly 10% of all beats, the risk of developing a weakened heart muscle, called PVC-induced cardiomyopathy, rises substantially. This is a condition where the heart’s pumping function declines specifically because of the PVCs themselves, and it is potentially reversible if the PVCs are brought under control.7PubMed Central. Premature Ventricular Complex-induced Cardiomyopathy
A state-of-the-art review in the Journal of the American College of Cardiology recommended that arrhythmia-induced cardiomyopathy should be considered in any patient with AFib, a resting heart rate consistently above 100, or a PVC burden above 10%.8PubMed. Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review When AFib and frequent PVCs are both present, the heart is essentially getting hit from two directions: the atria are fibrillating and driving the ventricles irregularly, while the ventricles are also firing on their own out of turn. This double burden accelerates the decline in heart function. A Circulation review noted that increased PVC frequency is a risk factor for heart failure and death, and that the reversal of heart-muscle weakness after successful PVC ablation proves the PVCs themselves were the cause.9Circulation. Evaluation and Management of Premature Ventricular Complexes
Stroke Risk in AFib Patients with High PVC Burden
AFib is already the most common cardiac cause of stroke, and anticoagulation decisions are a cornerstone of AFib management. What is less widely known is that a high PVC burden can independently amplify stroke risk in AFib patients. A study of nearly 5,000 patients with non-valvular AFib who were not on anticoagulants found that those with a daily PVC burden of 10% or higher had more than double the rate of ischemic stroke compared to those below that threshold, even after adjusting for the standard stroke-risk scoring system and other variables like heart function and atrial size.10PubMed Central. Impact of Premature Ventricular Complex Burden on Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation
This finding has practical implications. If you have AFib and your doctor is weighing the risks and benefits of blood thinners, a high PVC burden may tip the scales toward anticoagulation even if your traditional stroke-risk score falls in a gray zone. The mechanism likely involves worsened blood stasis in the atrium: PVCs disrupt the coordinated emptying of the heart’s chambers, and in a heart already fibrillating, that translates to more sluggish blood flow and a higher chance of clot formation.
Medication Options
Drug therapy for the combination of AFib and PVCs serves two overlapping goals: controlling the ventricular rate during AFib and suppressing the PVCs themselves. The first-line medications for AFib rate control are beta-blockers and calcium channel blockers, and both also help reduce PVC frequency to some degree. A large comparison of these two drug classes for AFib rate control found that both achieved a target resting heart rate below 110 beats per minute in about 92% of patients, but calcium channel blockers caused significantly less slow-heart-rate episodes during normal rhythm, which matters if your heart flips between AFib and regular rhythm.11Heart. Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers In practice, beta-blockers are often tried first because they address both the fast rate during AFib and the extra beats from PVCs, but calcium channel blockers are a reasonable alternative, especially if fatigue or excessively slow heart rate becomes a problem.
When PVCs persist despite rate-control medications, antiarrhythmic drugs like flecainide or amiodarone may be added. Flecainide is effective at suppressing PVCs in most patients, though early studies noted it did not convert AFib itself. In one trial, PVCs were suppressed for an average of 13 hours after dosing in responsive patients, but AFib episodes continued unaffected.12PubMed Central. Antiarrhythmic effects of flecainide This is worth understanding: a drug can quiet the PVCs without fixing the AFib, which means you may still need a separate strategy for the atrial arrhythmia. Amiodarone, while more broadly effective against both rhythm problems, carries significant long-term side effects involving the thyroid, lungs, and liver, so it is typically reserved for cases where other options have failed.
The quality-of-life data on PVC treatment is encouraging. Across studies of patients treated with beta-blockers, calcium channel blockers, class I or class III antiarrhythmics, and catheter ablation, successful PVC reduction consistently improved depression and anxiety scores.4Oxford Academic (EP Europace). Premature ventricular contractions and quality of life: a state-of-the-art review and psychological perspective This suggests that even partial suppression of PVCs can meaningfully improve how patients feel day to day.
Catheter Ablation for PVCs When AFib Is Also Present
When medications are not enough, catheter ablation can target the specific spot in the ventricle where PVCs originate and destroy it with heat or freezing energy. Ablation is particularly attractive when PVC burden is high enough to threaten heart function, because the resulting cardiomyopathy is potentially reversible once the PVCs stop.7PubMed Central. Premature Ventricular Complex-induced Cardiomyopathy In patients who also have AFib, there is sometimes a decision about whether to ablate just the PVCs, just the AFib, or both. The answer depends on which arrhythmia is driving symptoms and harming the heart more.
If high PVC burden appears to be causing left atrial dilation and triggering AFib episodes, eliminating the PVCs first can prevent or reverse the atrial remodeling that sustains AFib.3PubMed Central. Atrial and Ventricular Response to Treatment of Premature Ventricular Complexes On the other hand, if the AFib is long-standing and the PVCs are more of a nuisance, AFib ablation may take priority. Some patients undergo staged procedures: PVC ablation first, then AFib ablation if AFib persists once the PVC burden is under control. This sequencing reflects the understanding that removing the PVC trigger may resolve the AFib without needing a second procedure.
Monitoring PVC Burden Accurately
Knowing your PVC burden matters for treatment decisions, but measuring it accurately is harder than it sounds. The traditional gold standard is a 24-hour Holter monitor, which records every heartbeat for a full day and gives a precise count. Newer implantable cardiac monitors can track rhythm continuously over months, which captures day-to-day variability that a single Holter snapshot may miss. A validation study of one such implantable device showed a strong correlation with simultaneous Holter recordings, though the implant tended to slightly underestimate the true PVC burden, particularly in the moderate range.13PubMed Central. Premature ventricular contraction detection and estimation of daily burden by an insertable cardiac monitor
Patients who already have a pacemaker or defibrillator might assume those devices track PVCs well, but the evidence is less reassuring. A study comparing PVC burden detected by implanted cardiac devices versus ambulatory monitors found that the devices substantially underestimated the true burden. When the actual PVC burden was 15% or higher on an ambulatory monitor, the implanted device detected that same level only about 11% of the time.14PubMed. Performance of cardiac implantable electronic devices in detecting premature ventricular contraction burden This means that if your cardiologist is relying solely on data from your pacemaker or defibrillator, clinically important PVC burdens could be missed. A dedicated Holter or ambulatory monitor is still the most reliable way to quantify PVCs when the number matters for clinical decisions.
Device Therapy and Cardiac Resynchronization
For patients with heart failure, AFib, and frequent PVCs, implantable devices add another layer of complexity. Cardiac resynchronization therapy (CRT) uses a specialized pacemaker to coordinate the heart’s pumping, and it works best when nearly all beats are paced by the device. Frequent PVCs disrupt this pacing because each PVC is an unsynchronized beat that the device did not deliver. In a registry of CRT patients with high PVC burdens, the most common response was to do nothing specific about the PVCs: about four in five patients received no targeted PVC treatment, roughly one in five had their medications adjusted, and catheter ablation was rare.15PubMed Central. Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry This undertreatment is a concern because every PVC erodes the percentage of synchronized beats the device delivers, potentially undermining its benefit.
On the other hand, upgrading from a standard pacemaker or defibrillator to a CRT device can itself improve outcomes in heart failure patients with AFib. A randomized trial found that CRT upgrade reduced heart-failure hospitalizations and improved the heart’s structure in AFib patients to a similar degree as in patients with normal rhythm.16PubMed Central. Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation The interaction between PVCs, AFib, and device therapy is a space where cardiologists have to balance multiple competing factors, and optimal care usually requires periodic Holter monitoring to ensure the device is actually delivering the synchronized pacing it was implanted to provide.
Adults with Congenital Heart Disease
One population that deserves special mention is adults who were born with heart defects. These patients are already prone to arrhythmias because of the structural changes in their hearts, whether from the defect itself or from surgical repairs earlier in life. Both AFib and PVCs are common in this group, and the combination can cause tachycardia-induced cardiomyopathy, the same weakening of the heart muscle seen in other populations. However, less is known about how readily these patients recover their heart function once the arrhythmia is controlled, and the consequences of delayed diagnosis can be severe given their already compromised cardiac reserve.17Heart Rhythm / Elsevier. Arrhythmias in adults with congenital heart disease and heart failure If you have a congenital heart condition and notice worsening palpitations or exercise tolerance, that warrants an earlier and more aggressive workup than it might in someone with a structurally normal heart.
Lifestyle Triggers and Modifiable Factors
Beyond the structural and electrical factors, everyday habits influence both AFib and PVC frequency. Caffeine, alcohol, sleep deprivation, and emotional stress are all well-recognized triggers for both arrhythmias. Alcohol stands out as a particularly potent driver of AFib, and heavy drinking is associated with increased PVC frequency as well. The wearable-ECG data from the UK Biobank found that people with premature contractions were more likely to have higher body mass and Type 2 diabetes, though interestingly, smoking status and cholesterol levels did not differ significantly from those without extra beats.2European Heart Journal – Digital Health. Premature atrial and ventricular contractions detected on wearable-format electrocardiograms and prediction of cardiovascular events
Weight management and control of blood pressure and blood sugar appear to reduce both AFib recurrence and PVC burden over time. Exercise is a nuanced area: moderate physical activity is generally protective against AFib and helps reduce PVCs, but extreme endurance exercise has been linked to higher AFib risk in some studies. For most people with both conditions, steady moderate activity, weight loss if overweight, reducing alcohol, and improving sleep quality form a foundation that makes medications and procedures work better. None of these steps replace medical treatment when PVC burden is high or AFib is causing symptoms, but they address the soil in which both arrhythmias grow.